Despite high national demand, UPMC monoclonal antibody supply 'good'

The New York Times reported that orders for the two monoclonal antibodies under emergency use authorization from the U.S. Food and Drug Administration, have increased from 27,000 in July to 168,000 in August.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.